Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

US STOCKS-Markets fall on earnings caution, energy selloff

Published 04/11/2011, 04:23 PM
NDX
-
US500
-
DJI
-
AA
-
GOOGL
-
NDAQ
-
BIIB
-
WFC
-
NYX
-
THC
-
GC
-
CL
-
BIG
-
PMCN
-

* Alcoa falls ahead of reporting results

* Energy stocks fall as crude lower

* Tenet Healthcare sues Community Health Systems

* Dow up 0.01 pct, S&P down 0.3 pct, Nasdaq down 0.3 pct

* For up-to-the-minute market news see [STXNEWS/US] (Updates to close)

By Edward Krudy

NEW YORK, April 11 (Reuters) - Stocks mostly fell on Monday as energy shares sold off on lower oil prices, and as the earnings season onset was clouded by concern company outlooks may fall short of expectations.

Worries that increased raw material costs and the effects from Japan's earthquake may affect coming quarters will put companies' forward-looking statements under increased scrutiny.

Aluminum maker Alcoa Inc , a Dow component, launched the earnings season with the release of results after the market's close.

"Companies are going to be trying to dampen expectations for the second quarter," said Subodh Kumar, chief investment strategist at Subodh Kumar & Associates in Toronto. "The market focus is more internal as to whether it's gone up too fast.

Energy shares fell as U.S. crude futures slid on profit-taking. Occidental Petroleum fell 3.2 percent to $100.42 while the S&P energy index <.GSPE> fell 1.9 percent.

Profits for S&P 500 companies are seen rising 11.4 percent from a year ago, according to Thomson Reuters data, but much of that may be priced into shares. The S&P 500 is up over 5 percent this year. For details, see [ID:nN07256466]

Optimism over earnings contributed to recent gains, despite turmoil in oil-producing regions and the disasters in Japan. Despite the S&P 500's gains this year, light trading volume has prompted questions about the strength of the rally.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Dow Jones industrial average <.DJI> rose 1.06 points, or 0.01 percent, at 12,381.11. The Standard & Poor's 500 Index <.SPX> fell 3.71 points, or 0.28 percent, at 1,324.46. The Nasdaq Composite Index <.IXIC> lost 8.91 points, or 0.32 percent, at 2,771.51.

U.S. crude oil futures ended 2.5 percent lower as investors heeded a recommendation from top brokerage Goldman Sachs that they take profits after the recent rally.

Alcoa shares slid 0.8 percent to $17.77 after rising earlier. The company was seen posting growth in both earnings and revenue. JPMorgan Chase & Co and Google Inc are on tap to report later in the week.

In corporate news, Tenet Healthcare Corp said it has sued its suitor, Community Health Systems Inc , claiming the rival hospital operator admitted patients for unneeded stays to overbill insurers, including Medicare.

Shares of Tenet sank 14.7 percent to $6.44 while Community slumped 36 percent to $25.89. [ID:nN11291765]

NYSE Euronext on Sunday rejected a joint buyout bid from Nasdaq OMX Group and IntercontinentalExchange and said it was sticking with an earlier bid from Deutsche Boerse AG . Nasdaq reaffirmed that its offer was superior to Deutsche Boerse's lower offer. [ID:nN10204369]

NYSE shares fell 2.9 percent to $37.59 while Nasdaq OMX fell 1.5 percent to $28.03 and ICE was unchanged at $120.55.

Also in deal news, Endo Pharmaceuticals Holding Inc said it would buy American Medical Systems Holdings Inc for about $2.6 billion while Level 3 Communications Inc agreed to buy Global Crossing Ltd for $1.9 billion in stock. [ID:nL3E7FB1PZ] and [ID:nL3E7FB29F]

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Endo rose 0.5 percent to $41.06 while American Medical jumped 32 percent to $29.50. Level 3 rose 18.1 percent to $1.70 and Global Crossing surged 69 percent to $24.97.

Biogen Idec Inc rose 7.2 percent to $78.55 and was the top percentage gainer on the Nasdaq 100 <.NDX> after the company's experimental multiple sclerosis drug met the main goal in the first of two important late-stage studies. [ID:nN11283786] (Editing by Leslie Adler)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.